Immunofluorescence staining (Fig. 5A, B) and transcriptome data in TCGA database (Fig. S7A, B) showed that GRAMD1A expression was significantly higher in KRAS mutant CRC compared to KRAS wild-type CRC, and in CRC tissues compared to normal colon tissue. Here, GRAMD1A is linked to colorectal carcinoma.